Cell Source, Inc.
CLCS · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $15 | $14 | $30 | $36 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $10 | $9 | $8 | $6 |
| Enterprise Value | $25 | $24 | $37 | $42 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$4 | $0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$5 | -$5 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.15 | -0.17 | -0.18 | -0.19 |
| % Growth | 11.8% | 5.6% | 5.3% | – |
| Operating Cash Flow | -$3 | -$2 | -$3 | -$3 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$3 | -$2 | -$3 | -$3 |